Shenglan Tang, co-director of the Global Health Research Center at Duke Kunshan University, has co-authored a new commentary in the Lancet with Michael Merson calling for more far-reaching reform of the World Health Organization.
The commentary, “Transforming WHO: incremental reform is no longer sufficient,” was published April 10.

Beginning on November 10, 2025, China officially included the domestic-made bivalent human papillomavirus (HPV) vaccine into the National Immunization Program (NIP), providing two doses free of charge to girls aged 13 years. This measure marks a critical step in China’s participation in the global effort to eliminate cervical cancer and is also regarded as an important exploration in expanding immunization services from a focus on infants and young children toward a life-course approach. Consequently, the implementation of HPV vaccination under the NIP also carries an important mission: to lay the foundation for establishing the adolescent routine immunization service system.

As East and Southeast Asia ages rapidly, a new study involving researchers from Duke Kunshan University, Duke University and Duke-NUS Medical School maps the region’s long-term aging research landscape and identifies gaps in the data